A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
NCT02159651 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179
Last updated 2024-10-22
Summary
This study is to evaluate the safety and the efficacy of Prograf in patients with interstitial pneumonia associated with polymyositis / dermatomyositis in acute clinical setting.
Conditions
- Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Interventions
- DRUG
-
oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Medical Director · Astellas Pharma Inc
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-01
- Primary Completion
- 2019-12-23
- Completion
- 2019-12-23
Countries
- Japan
Study Locations
More Related Trials
-
A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
NCT02115997 ·Status: COMPLETED ·Phase: PHASE4
-
Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
NCT01813617 ·Status: COMPLETED
-
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
NCT05979441 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
NCT06046222 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256 ·Status: RECRUITING ·Phase: PHASE2
-
GC012F in Patients With Autoimmune Diseases
NCT07072884 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
GC012F Injection in Refractory Idiopathic Inflammatory Myopathy
NCT07086404 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis
NCT00987116 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
NCT06455449 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis
NCT03315130 ·Status: COMPLETED ·Phase: PHASE2
-
Interleukin and Autoantibodies in Myasthenia Gravis.
NCT05301153 ·Status: UNKNOWN
-
Study of M5049 in DM and PM Participants (NEPTUNIA)
NCT05650567 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
NCT05523167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
NCT01625182 ·Status: COMPLETED ·Phase: PHASE3
-
Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)
NCT01458171 ·Status: COMPLETED ·Phase: PHASE3
-
The Neuroprotective Effect of PEG-GCSF in the Traumatic Optic Neuropathy
NCT06168188 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832 ·Status: RECRUITING
-
A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)
NCT05681715 ·Status: COMPLETED ·Phase: PHASE3
-
Immunotherapy and Paraneoplastic Neurological Syndromes
NCT02343211 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)
NCT01199705 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of TAK-079 in People With Generalized Myasthenia Gravis
NCT04159805 ·Status: COMPLETED ·Phase: PHASE2
-
An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
NCT06759948 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis
NCT05986162 ·Status: UNKNOWN ·Phase: PHASE1
-
FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
NCT00309088 ·Status: COMPLETED ·Phase: PHASE3
-
Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)
NCT05868837 ·Status: RECRUITING ·Phase: PHASE3